AAAAAA

   
Results: 1-8 |
Results: 8
Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway
Authors: Cenni, B Aebi, S Nehme, A Christen, RD
Citation: B. Cenni et al., Epidermal growth factor enhances cisplatin-induced apoptosis by a caspase 3 independent pathway, CANC CHEMOT, 47(5), 2001, pp. 397-403
P53 modulates the effect of loss of DNA mismatch repair on the sensitivityof human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin
Authors: Lin, XJ Ramamurthi, K Mishima, M Kondo, A Christen, RD Howell, SB
Citation: Xj. Lin et al., P53 modulates the effect of loss of DNA mismatch repair on the sensitivityof human colon cancer cells to the cytotoxic and mutagenic effects of cisplatin, CANCER RES, 61(4), 2001, pp. 1508-1516
Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells
Authors: Nehme, A Varadarajan, P Sellakumar, G Gerhold, M Niedner, H Zhang, Q Lin, X Christen, RD
Citation: A. Nehme et al., Modulation of docetaxel-induced apoptosis and cell cycle arrest by all-trans retinoic acid in prostate cancer cells, BR J CANC, 84(11), 2001, pp. 1571-1576
Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel
Authors: de las Alas, MM Christen, RD Gately, DP Weiner, DE Benbatoul, K Kirmani, S D'Agostino, HR Plaxe, SC Darrah, D McClay, EF Aebi, S Howell, SB Los, G
Citation: Mm. De Las Alas et al., Increase in tumor GADD153 mRNA level following treatment correlates with response to paclitaxel, CANC CHEMOT, 45(5), 2000, pp. 381-388
Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage
Authors: Nehme, A Lee, BL Baskaran, R Zhang, Q Lin, X Christen, RD
Citation: A. Nehme et al., Effect of c-Abl tyrosine kinase on the cellular response to paclitaxel-induced microtubule damage, BR J CANC, 83(10), 2000, pp. 1360-1366
A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel
Authors: Aebi, S Schnider, TW Los, G Heath, DD Darrah, D Kirmani, S McClay, EF D'Agostino, H Plaxe, SC Fink, D De las Alas, MM Howell, SB Christen, RD
Citation: S. Aebi et al., A phase II/pharmacokinetic trial of high-dose progesterone in combination with paclitaxel, CANC CHEMOT, 44(3), 1999, pp. 259-265
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin
Authors: Cenni, B Kim, HK Bubley, GJ Aebi, S Fink, D Teicher, BA Howell, S Christen, RD
Citation: B. Cenni et al., Loss of DNA mismatch repair facilitates reactivation of a reporter plasmiddamaged by cisplatin, BR J CANC, 80(5-6), 1999, pp. 699-704
Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells
Authors: Nehme, A Baskaran, R Nebel, S Fink, D Howell, SB Wang, JYJ Christen, RD
Citation: A. Nehme et al., Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells, BR J CANC, 79(7-8), 1999, pp. 1104-1110
Risultati: 1-8 |